Lipoprotein(a) is associated with coronary atheroma progression:analysis from a serial coronary computed tomography angiography study

被引:0
|
作者
Xi WANG [1 ,2 ]
Dong-Kai SHAN [2 ]
Guan-Hua DOU [3 ]
Yi-Pu DING [4 ]
Jing JING [2 ]
He-Bin CHE [5 ]
Jun-Jie YANG [2 ]
Yun-Dai CHEN [2 ]
机构
[1] Medical School of Chinese PLA
[2] Department of Cardiology, the Sixth Medical Centre, Chinese PLA General Hospital
[3] Department of Cardiology, the Second Medical Centre, Chinese PLA General Hospital
[4] School of Medicine, Nankai University
[5] Medical Big Data Research Centre, Chinese PLA General Hospital
关键词
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Lipoprotein(a) [Lp(a)] has been closely related to coronary atherosclerosis and might affect perivascular inflammation due to its proinflammatory properties. However, there are limited data about Lp(a) and related perivascular inflammation on coronary atheroma progression. Therefore, this study aimed to investigate the associations between Lp(a) and the perivascular fat attenuation index(FAI) with coronary atheroma progression detected by coronary computed tomography angiography(CCTA).METHODS Patients who underwent serial CCTA examinations without a history of revascularization and with available data for Lp(a) within one month before or after baseline and follow-up CCTA imaging scans were considered to be included. CCTA quantitative analyses were performed to obtain the total plaque volume(TPV) and the perivascular FAI. Coronary plaque progression(PP) was defined as a ≥ 10% increase in the change of the TPV at the patient level or the presence of new-onset coronary atheroma lesions. The associations between Lp(a) or the perivascular FAI with PP were examined by multivariate logistic regression.RESULTS A total of 116 patients were ultimately enrolled in the present study with a mean CCTA interscan interval of 30.80 ±13.50 months. Among the 116 patients(mean age: 53.49 ± 10.21 years, males: 83.6%), 32 patients presented PP during the followup interval. Lp(a) levels were significantly higher among PP patients than those among non-PP patients at both baseline [15.80(9.09-33.60) mg/d L vs. 10.50(4.75-19.71) mg/d L, P = 0.029] and follow-up [20.60(10.45-34.55) mg/d L vs. 8.77(5.00-18.78) mg/d L,P = 0.004]. However, there were no differences in the perivascular FAI between PP group and non-PP group at either baseline or follow-up. Multivariate logistic regression analysis showed that elevated baseline Lp(a) level(OR = 1.031, 95% CI: 1.005-1.058, P =0.019) was an independent risk factor for PP after adjustment for other conventional variables.CONCLUSIONS Lp(a) was independently associated with coronary atheroma progression beyond low-density lipoprotein cholesterol and other conventional risk factors. Further studies are warranted to identify the inflammation effect exhibited as the perivascular FAI on coronary atheroma progression.
引用
收藏
页码:996 / 1007
页数:12
相关论文
共 50 条
  • [1] Lipoprotein(a) is associated with coronary atheroma progression: analysis from a serial coronary computed tomography angiography study
    Wang, Xi
    Shan, Dong-Kai
    Dou, Guan-Hua
    Ding, Yi-Pu
    Jing, Jing
    Che, He-Bin
    Yang, Jun-Jie
    Chen, Yun-Dai
    [J]. JOURNAL OF GERIATRIC CARDIOLOGY, 2021, 18 (12) : 996 - 1007
  • [2] Factors Associated With Coronary Artery Disease Progression Assessed by Serial Coronary Computed Tomography Angiography
    Camargo, Gabriel C.
    Rothstein, Tamara
    Derenne, Maria Eduarda
    Sabioni, Leticia
    Calafate, Isadora R.
    Xavier, Carolina A.
    Marcomini, Livia G.
    Lima, Ronaldo S.
    Gottlieb, Ilan
    [J]. CIRCULATION, 2013, 128 (22)
  • [3] Factors Associated With Coronary Artery Disease Progression Assessed By Serial Coronary Computed Tomography Angiography
    Camargo, Gabriel Cordeiro
    Rothstein, Tamara
    Derenne, Maria Eduarda
    Sabioni, Leticia
    Lima, Joao A. C.
    Leao Lima, Ronaldo de Souza
    Gottlieb, Ilan
    [J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2017, 108 (05) : 396 - 404
  • [4] Implications of serial coronary computed tomography angiography in the evaluation of coronary plaque progression
    Dahal, Suraj
    Budoff, Matthew J.
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2019, 30 (06) : 446 - 451
  • [5] The Determinant of Coronary artery plaque progression by serial coronary computed tomography angiography (ACCORSS study)
    Shin, S.
    Park, H. B.
    Choi, J. H.
    Lee, B. K.
    Kim, Y. J.
    Chang, H. J.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 623 - 623
  • [6] Effect of Statins on Coronary Plaque Progression Assessed by Serial Coronary Computed Tomography Angiography
    Dahal, Suraj
    Lakshmanan, Suvasini
    Ahmad, Khadije
    Rezvanizadeh, Vahid
    Ghanem, Ahmed K.
    Onuegbu, Afiachukwu G.
    Birudaraju, Divya
    Kinninger, April
    Golub, Ilana
    Hamal, Sajad
    Dailing, Christopher
    Flores, Fred
    Roy, Sion
    Budoff, Matthew J.
    [J]. CIRCULATION, 2020, 142
  • [7] Characteristics of plaque progression detected by serial coronary computed tomography angiography
    Hajime Ito
    Sadako Motoyama
    Masayoshi Sarai
    Hideki Kawai
    Hiroto Harigaya
    Shino Kan
    Shigeru Kato
    Hirofumi Anno
    Hiroshi Takahashi
    Hiroyuki Naruse
    Junichi Ishii
    Jagat Narula
    Yukio Ozaki
    [J]. Heart and Vessels, 2014, 29 : 743 - 749
  • [8] Characteristics of plaque progression detected by serial coronary computed tomography angiography
    Ito, Hajime
    Motoyama, Sadako
    Sarai, Masayoshi
    Kawai, Hideki
    Harigaya, Hiroto
    Kan, Shino
    Kato, Shigeru
    Anno, Hirofumi
    Takahashi, Hiroshi
    Naruse, Hiroyuki
    Ishii, Junichi
    Narula, Jagat
    Ozaki, Yukio
    [J]. HEART AND VESSELS, 2014, 29 (06) : 743 - 749
  • [9] Plaque Progression Detected by Serial Coronary Computed Tomography Angiography Predicts Acute Coronary Syndromes
    Ito, Hajime
    Motoyama, Sadako
    Sarai, Masayoshi
    Kawai, Hideki
    Harigaya, Hiroto
    Kan, Shino
    Naruse, Hiroyuki
    Ishi, Junichi
    Ozaki, Yukio
    [J]. CIRCULATION, 2013, 128 (22)
  • [10] Effect of Evolocumab on Vulnerable Coronary Plaques: A Serial Coronary Computed Tomography Angiography Study
    Hirai, Keiji
    Imamura, Shigeki
    Hirai, Aizan
    Ookawara, Susumu
    Morishita, Yoshiyuki
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (10) : 1 - 16